WM

NW Natural Holdings Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Friday, February 23, 2024
Oil, Gas, Energy, Acquisition, WM, DBA, Oregon Public Utility Commission, Investment, Natural gas, NW, Growth, NWN, Safety, NW Natural, Waste management, Information technology, PGA, OPUC, Mist, Water, RNG, Renewable energy

2022 earnings per share were $2.54

Key Points: 
  • 2022 earnings per share were $2.54
    "For over 165 years, NW Natural Holdings has provided essential energy to the communities it serves.
  • For 2023, NW Natural Holdings reported net income of $93.9 million (or $2.59 per share), compared to $86.3 million (or $2.54 per share) for 2022.
  • NW Natural Water launched its services business in April 2023 and completed a second acquisition in October 2023.
  • NW Natural Holdings' annual results by business segment are summarized in the table below:

Alloy.ai Partners with WM Barr to Transform Its Sales Capabilities and Retail Relationships

Retrieved on: 
Tuesday, February 13, 2024
Supply Chain Management, Data Management, Retail, Technology, Software, Specialty, Internet, Marketing, Sale, WM, Warehouse

Founded in 1946 by William M. Barr, the company quickly became an icon in the home improvement and automotive repair industries.

Key Points: 
  • Founded in 1946 by William M. Barr, the company quickly became an icon in the home improvement and automotive repair industries.
  • WM Barr selected Alloy.ai because of the platform’s ability to automatically aggregate and normalize data from 850+ retailers and supply chain partners, then provide real-time analytics to power sales, marketing and supply chain decisions.
  • “Converting data into valuable insights that help us better manage our portfolio is critical, partnering with Alloy.ai will help us accelerate this capability for WM Barr,” said Ricardo Gonzalez-Alduenda, VP of Sales at WM Barr.
  • “We’re excited that a leading brand like WM Barr selected Alloy.ai,” said Joel Beal, CEO and Co-founder at Alloy.ai.

WM Announces Fourth Quarter and Full-Year 2023 Earnings

Retrieved on: 
Monday, February 12, 2024
Other Transport, Energy, Environment, Transport, Utilities, Conference call, Collection, WM, Investment, Share repurchase, Natural gas, British thermal unit, Growth, Municipal solid waste, Lynch, Recycling, Conference, Waste management, GAAP, Depreciation, Automation, Public expenditure, Bank statement, Renewable energy

“During the fourth quarter, our collection and disposal business performance powered our total Company adjusted operating EBITDA growth of 15% and record adjusted margin of 29.9%.

Key Points: 
  • “During the fourth quarter, our collection and disposal business performance powered our total Company adjusted operating EBITDA growth of 15% and record adjusted margin of 29.9%.
  • SG&A expenses were 9.8% of revenue compared to 9.9%, or 9.8% on an adjusted basis, in the fourth quarter of 2022.
  • (a)
    Operating EBITDA in the Collection and Disposal business grew $250 million, or $205 million on an adjusted basis, to $1.77 billion.
  • ET on February 13, 2024 to discuss the fourth quarter and full-year 2023 results.

Wynn Resorts, Limited Reports Fourth Quarter and Year End 2023 Results

Retrieved on: 
Wednesday, February 7, 2024
Entertainment, Vacation, Lodging, Destinations, Travel, Tourist Attractions, Casino, Gaming, Resort, Encore Boston Harbor, WM, WYNN, WRF, WML, Investment, Wynn Las Vegas, Tourism, Corporation, Interest, Wynn Palace, Video game

Wynn Resorts, Limited (NASDAQ: WYNN) ("Wynn Resorts" or the "Company") today reported financial results for the fourth quarter ended December 31, 2023.

Key Points: 
  • Wynn Resorts, Limited (NASDAQ: WYNN) ("Wynn Resorts" or the "Company") today reported financial results for the fourth quarter ended December 31, 2023.
  • Net income attributable to Wynn Resorts, Limited was $729.2 million for the fourth quarter of 2023, compared to net income attributable to Wynn Resorts, Limited of $32.4 million for the fourth quarter of 2022.
  • Net income attributable to Wynn Resorts, Limited was $729.2 million for the fourth quarter of 2023, compared to net income attributable to Wynn Resorts, Limited of $32.4 million for the fourth quarter of 2022.
  • Adjusted Property EBITDAR from Wynn Macau was $125.8 million for the fourth quarter of 2023, compared to $(35.2) million for the fourth quarter of 2022.

Tau Group Closes €11 Million Extension to Series-B Round to Fuel Growth and Enhance Production Capacity

Retrieved on: 
Tuesday, January 30, 2024
Tau, WM, Overalls, Financial institution, Investment, Aluminium, Ecosystem, Growth, CVC, EUR, Transport, Copper, Economic development, CDP Equity, Renewable energy

Tau has successfully closed a €11 million extension to its Series-B funding round.

Key Points: 
  • Tau has successfully closed a €11 million extension to its Series-B funding round.
  • Tau Group stands at the forefront of the energy transition, specializing in the decarbonization of energy and electrification of transport.
  • The funds raised in this extension will propel Tau Group's growth trajectory, enhancing its ability to achieve ambitious goals.
  • Tau Group is a technology company at the core of energy transition, decarbonization of energy and electrification of transport.

Tau Group Closes €11 Million Extension to Series-B Round to Fuel Growth and Enhance Production Capacity

Retrieved on: 
Tuesday, January 30, 2024
Tau, WM, Overalls, Financial institution, Investment, Aluminium, Ecosystem, Growth, CVC, EUR, Transport, Copper, Economic development, CDP Equity, Renewable energy

Tau has successfully closed a €11 million extension to its Series-B funding round.

Key Points: 
  • Tau has successfully closed a €11 million extension to its Series-B funding round.
  • Tau Group stands at the forefront of the energy transition, specializing in the decarbonization of energy and electrification of transport.
  • The funds raised in this extension will propel Tau Group's growth trajectory, enhancing its ability to achieve ambitious goals.
  • Tau Group is a technology company at the core of energy transition, decarbonization of energy and electrification of transport.

Stock Yards Bancorp Reports Fourth Quarter Earnings of $23.9 Million or $0.82 Per Diluted Share and Record Earnings for the Year

Retrieved on: 
Wednesday, January 24, 2024
Record, WM, American Banker, CECL, Total, Commercial property, C&I, Bank, Treasury, Condition, FHLB, Raymond James Financial, Construction, Commercial, Stockyard, Growth, Environment, Sale, Investment, Federal Home Loan Banks, Pressure, Depreciation, Letter, Projection, Federal Reserve Bank, AUM, PPP, Unemployment, Visa

Key factors contributing to the fourth quarter of 2023 results included:

Key Points: 
  • Key factors contributing to the fourth quarter of 2023 results included:
    Loan growth and loan production represented the best fourth quarter in the Company’s history.
  • Deposit balances expanded $268 million, or 4%, on the linked quarter, as interest bearing deposits grew $434 million and non-interest bearing deposits contracted by $166 million.
  • Net interest income declined $3.2 million, or 5%, for the fourth quarter of 2023 compared to the fourth quarter a year ago, with net interest margin compressing 39 bps to 3.25%.
  • WM&T income ended the fourth quarter of 2023 at $10.1 million, increasing $878,000, or 10%, over the fourth quarter of 2022.

Marketers Given Marginal Grades for ABM-Driven Revenue Growth

Retrieved on: 
Tuesday, January 23, 2024
Momentum, Table, WM, Research, Finance Secretary (India), ABM, SAN, Intelligence, Business marketing, T-Mobile, IBM, TechTarget, Xometry, Investment, CMO, CMOS, Marketing, LEAP, NTT, Growth, Sales

A new Chief Marketing Officer (CMO) Council report, produced in collaboration with WM America, entitled “ Fire Up Your Revenue Generation Engine ,” covers critical aspects of lead generation and engagement.

Key Points: 
  • A new Chief Marketing Officer (CMO) Council report, produced in collaboration with WM America, entitled “ Fire Up Your Revenue Generation Engine ,” covers critical aspects of lead generation and engagement.
  • This includes models and metrics for tracking and measuring performance, best practice demand-gen execution, ways to score effectiveness, and more.
  • The latest CMO Council research finds scores of marketers falling behind in lead scoring, account-based marketing, accelerated pipeline, and intention-based marketing.
  • The report is based on a survey of over 170 heads of B2B marketing, sales, revenue, growth, demand gen and campaign execution in Q4 2023.

Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient

Retrieved on: 
Monday, January 22, 2024
WM, Patient, Syndrome, BNS, Harvard Medical School, Dana–Farber Cancer Institute, Cancer, NCI, Mutation, Traffic barrier, Malignancy, MYD88, Cerebrospinal fluid, CNSL, CNS, Pharmaceutical industry

“Attainment of complete CNS clearance in a patient with Bing-Neel Syndrome after previous exposure to BTKi therapy is encouraging,” commented Jorge Castillo, M.D., associate professor at Harvard Medical School and director of Bing Center Clinic at Dana Farber Cancer Institute.

Key Points: 
  • “Attainment of complete CNS clearance in a patient with Bing-Neel Syndrome after previous exposure to BTKi therapy is encouraging,” commented Jorge Castillo, M.D., associate professor at Harvard Medical School and director of Bing Center Clinic at Dana Farber Cancer Institute.
  • Cerebrospinal fluid flow cytometry showed no evidence of clonal B-cells, and molecular analysis did not detect the MYD88 mutation.
  • This very encouraging patient response further supports iopofosine’s development in CNS-related malignancies, including CNS lymphoma and pediatric high-grade gliomas.”
    Cellectar previously announced a complete response in a patient with relapsed/refractory primary central nervous system lymphoma (CNSL) as part of its ongoing Phase 2a trial of iopofosine I 131.
  • The study objective is to identify the recommended iopofosine I 131 Phase 2 dose in pHGG patients.

Cellectar Biosciences Partners with MiBA, a Data Subsidiary of American Oncology Network, to Advance the Treatment of Waldenstrom's Macroglobulinemia in the Community Setting

Retrieved on: 
Thursday, January 11, 2024
Waldenström macroglobulinemia, WM, Patient, AON, Partnership, PDC, MRR, Cancer, Food, Safety, FDA, Macroglobulinemia, Physician, Pharmaceutical industry

"AON is currently managing over 650 Waldenstrom’s macroglobulinemia patients,” said Dr. Fred Divers, chief medical officer of AON.

Key Points: 
  • "AON is currently managing over 650 Waldenstrom’s macroglobulinemia patients,” said Dr. Fred Divers, chief medical officer of AON.
  • “We are committed to providing promising new radiotherapies, starting with Cellectar’s iopofosine I 131, a novel phospholipid radiotherapeutic conjugate, throughout our nationwide network of clinics.
  • Iopofosine I 131 was well tolerated and its toxicity profile was consistent with the Company's previously reported safety data.
  • Currently there are limited treatment options with only one approved class of drugs and no established standard of care beyond second-line therapy.